OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the Oxytocin System: New Pharmacotherapeutic Approaches
Damien W. Gulliver, Eryn L. Werry, Tristan A. Reekie, et al.
Trends in Pharmacological Sciences (2018) Vol. 40, Iss. 1, pp. 22-37
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Is Oxytocin “Nature’s Medicine”?
C. Sue Carter, William M. Kenkel, Evan L. MacLean, et al.
Pharmacological Reviews (2020) Vol. 72, Iss. 4, pp. 829-861
Open Access | Times Cited: 288

The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
S P H Alexander, Arthur Christopoulos, Anthony P. Davenport, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. S2
Open Access | Times Cited: 220

Chronic oxytocin administration stimulates the oxytocinergic system in children with autism
Matthijs Moerkerke, Nicky Daniëls, Laura Tibermont, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16

Oxytocin and the Neurobiology of Prosocial Behavior
Nina Marsh, Abigail A. Marsh, Mary R. Lee, et al.
The Neuroscientist (2020) Vol. 27, Iss. 6, pp. 604-619
Open Access | Times Cited: 102

Translational aspect in peptide drug discovery and development: An emerging therapeutic candidate
Uttpal Anand, Anustup Bandyopadhyay, Niraj Kumar Jha, et al.
BioFactors (2022) Vol. 49, Iss. 2, pp. 251-269
Open Access | Times Cited: 40

Challenges and Opportunities in Central Nervous System Drug Discovery
Jonathan J. Danon, Tristan A. Reekie, Michael Kassiou
Trends in Chemistry (2019) Vol. 1, Iss. 6, pp. 612-624
Open Access | Times Cited: 69

Classical Psychedelics as Therapeutics in Psychiatry – Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders
Lea J. Mertens, Katrin H. Preller
Pharmacopsychiatry (2021) Vol. 54, Iss. 04, pp. 176-190
Closed Access | Times Cited: 52

Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder
Patrick Schnider, Caterina Bissantz, Andreas Bruns, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 4, pp. 1511-1525
Closed Access | Times Cited: 51

Oxytocin and vasopressin signaling in health and disease
Monika Perisic, Katrina Woolcock, Anke Hering, et al.
Trends in Biochemical Sciences (2024) Vol. 49, Iss. 4, pp. 361-377
Open Access | Times Cited: 7

Modulation of Social Cognition via Hallucinogens and “Entactogens”
Katrin H. Preller, Franz X. Vollenweider
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 51

OXTRHigh stroma fibroblasts control the invasion pattern of oral squamous cell carcinoma via ERK5 signaling
Liang Ding, Yong Fu, Nisha Zhu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 22

A bench-to-bedside narrative review of the sleep-social-oxytocin nexus.
Joel S. Raymond, Wendy Troxel, Michael T. Bowen
Sleep Medicine Reviews (2025) Vol. 81, pp. 102077-102077
Closed Access

Nicotinamide riboside supplementation corrects deficits in oxytocin, sociability and anxiety of CD157 mutants in a mouse model of autism spectrum disorder
Maria Gerasimenko, Stanislav M. Cherepanov, Kazumi Furuhara, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 33

Participatory Art Activities Increase Salivary Oxytocin Secretion of ASD Children
Sanae Tanaka, Aiko Komagome, Aya Iguchi-Sherry, et al.
Brain Sciences (2020) Vol. 10, Iss. 10, pp. 680-680
Open Access | Times Cited: 32

Neuropeptides and oligopeptidases in schizophrenia
Benjamín Rodríguez, João V. Nani, Priscila G.C. Almeida, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 108, pp. 679-693
Closed Access | Times Cited: 32

Limbic Neuropeptidergic Modulators of Emotion and Their Therapeutic Potential for Anxiety and Post-Traumatic Stress Disorder
Paul J. Marvar, Raül Andero, René Hurlemann, et al.
Journal of Neuroscience (2021) Vol. 41, Iss. 5, pp. 901-910
Open Access | Times Cited: 26

The distribution of neuroligin4, an autism-related postsynaptic molecule, in the human brain
Akie Toya, Masahide Fukada, Eiko Aoki, et al.
Molecular Brain (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 10

Emerging pharmacological therapies in fragile X syndrome and autism
Hidenori Yamasue, Adi Aran, Elizabeth Berry‐Kravis
Current Opinion in Neurology (2019) Vol. 32, Iss. 4, pp. 635-640
Closed Access | Times Cited: 26

Oxytocin signaling in the treatment of drug addiction: Therapeutic opportunities and challenges
Xiaohang Che, Jialing Cai, Yueyang Liu, et al.
Pharmacology & Therapeutics (2021) Vol. 223, pp. 107820-107820
Closed Access | Times Cited: 19

Nature-inspired dimerization as a strategy to modulate neuropeptide pharmacology exemplified with vasopressin and oxytocin
Zoltan Dekan, Thomas Kremsmayr, Peter Keov, et al.
Chemical Science (2021) Vol. 12, Iss. 11, pp. 4057-4062
Open Access | Times Cited: 18

Maternal Diabetes-Induced Suppression of Oxytocin Receptor Contributes to Social Deficits in Offspring
Jianbo Liu, Yujie Liang, Xing Jiang, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 17

Serum Oxytocin Level Correlates With Gut Microbiome Dysbiosis in Children With Autism Spectrum Disorder
Minshi Huang, Kevin Liu, Zhen Wei, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 17

Page 1 - Next Page

Scroll to top